•
Apr 01, 2023

Masimo Q1 2023 Earnings Report

Masimo's financial performance showed solid growth, driven by healthcare segment and consumer business exceeding expectations.

Key Takeaways

Masimo reported consolidated revenue of $565.0 million, representing an 85.7% increase compared to the first quarter of 2022. Healthcare revenue grew by 14.0%, while non-healthcare revenue was $218.3 million. GAAP earnings per diluted share were $0.39, and non-GAAP earnings per diluted share were $0.87.

Consolidated revenue reached $565.0 million.

Healthcare revenue was $346.7 million, with 14.0% reported growth.

Non-healthcare revenue amounted to $218.3 million.

GAAP earnings per diluted share stood at $0.39, while non-GAAP earnings per diluted share was $0.87.

Total Revenue
$565M
Previous year: $304M
+85.7%
EPS
$0.87
Previous year: $0.93
-6.5%
Gross Profit
$285M
Previous year: $215M
+32.5%
Cash and Equivalents
$174M
Previous year: $720M
-75.8%
Free Cash Flow
-$8.1M
Previous year: $2.7M
-400.0%
Total Assets
$3.12B
Previous year: $1.91B
+63.2%

Masimo

Masimo

Forward Guidance

The company provided estimates for its updated full-year 2023 guidance.